Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Checklists · STROBE (cohort)

The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional

The cohort-specific STROBE checklist shares 22 items with the case-control and cross-sectional variants, but items 6, 12(d), 14(c) and 15 are worded specifically around exposed/unexposed groups, loss to follow-up and outcome events over time.

Pubrica AcademyWritten by the medical writing and biostatistics teams Reviewed byPubrica biostatistics team Published8 October 2026 Last checked8 October 2026 Reading time6 minutes

This is the cohort variant of the STROBE Statement — the checklist for studies in which groups defined by exposure status are followed over time to compare outcome incidence. See the STROBE overview for the shared structure across all three designs.

What it is

von Elm E, Altman DG, Egger M, Pocock SJ, Götzsche PC, Vandenbroucke JP, for the STROBE Initiative, 2007; EQUATOR Network checklist v4, cohort-specific edition.

To give a consistent, agreed set of items for reporting cohort studies — prospective or retrospective — so readers can judge bias, generalisability and validity. The authors state this is solely about reporting clarity, not study design or a quality score.

Cohort studies specifically, both prospective and retrospective/historical, in which participants classified by exposure status are followed to assess one or more outcomes. Not for case-control or cross-sectional designs, which have their own variants.

Is this the right tool?

Use it when

Authors reporting a cohort study, while drafting and at submission to journals requiring STROBE compliance. Researchers designing a cohort study can consult it early so follow-up time and loss-to-follow-up data are actually collected.

Not the right tool when

Case-control or cross-sectional studies should use their own matching STROBE variant — the cohort wording for items 6, 12(d), 14(c) and 15 is built around follow-up concepts (person-time, loss to follow-up) that do not map onto those designs. Not a tool for scoring methodological quality.

The checklist (cohort wording)

22 items; the four that carry cohort-specific wording are marked with an asterisk.

Title through methods

ItemWhat it requires
1. Title/abstractState “cohort study” in the title or abstract; give a balanced summary.
2–3. IntroductionBackground/rationale and specific objectives.
4–5. Design and settingKey design elements up front; setting, locations, recruitment/exposure/follow-up dates.
6*. ParticipantsEligibility, selection sources and follow-up methods; matching criteria and exposed/unexposed counts if matched.
7–11. Variables and methodsOutcomes/exposures/confounders defined; data sources; bias efforts; study size; quantitative-variable handling.
12*. Statistical methodsConfounding, subgroups, missing data, sensitivity analyses, and how loss to follow-up was addressed.

Results, discussion, funding

ItemWhat it requires
13. ParticipantsNumbers at each stage, separately for exposed and unexposed, ideally with a flow diagram.
14*. Descriptive dataCharacteristics by exposure group, missing data, and follow-up time summarised (average/total).
15*. Outcome dataOutcome events or summary measures over time, separately by exposure group.
16–17. Main and other resultsAdjusted/unadjusted estimates with precision; subgroup/sensitivity analyses.
18–22. Discussion and fundingKey results, limitations/bias direction, interpretation, generalisability, funding.

Applying it, with the evidence

Two Iranian audits a few years apart give a before/after picture. In a 2009 review of 60 cohort studies published before STROBE existed, a participant flow diagram (now item 13c) appeared in only 30% of papers. In a 2011 review of 60 cohort studies published after STROBE, 23.6% of applicable items were still unreported, and items such as efforts to address bias and the flow diagram were each missing in 85% of papers. A larger review of 37 CKD cohort studies found the item that improved most after STROBE was reporting losses to follow-up (0% before vs 36% after) — exactly what a reader needs to judge whether attrition biased the results.

The cohort checklist is heaviest used in clinical epidemiology, nephrology and CKD research, oncology risk-factor studies, cardiovascular and diabetes longitudinal research, and allergy/immunology — fields built on prospective or retrospective follow-up of a defined population tracking incidence, mortality or progression.

In order

Confirm the designExposure-defined groups followed forward or reconstructed retrospectively — not case-control or cross-sectional.
Draft item 6 with follow-up detailEligibility, selection sources, follow-up methods, and matching criteria if matched.
Report 13–15 by exposure groupSeparately for exposed and unexposed, with follow-up time quantified, not just described.
Spell out how loss to follow-up was handledItem 12(d) — censoring, imputation or a sensitivity analysis excluding dropouts.

Where it goes right

With it — no verifiable example found

Our research for this page did not turn up a named, checkable published paper that explicitly credits this checklist for a well-reported study. Rather than invent one, we are saying so. If you know of one, the EQUATOR Network page for this guideline is the place such examples tend to get collected.

Common mistakes

  • Loss to follow-up and total follow-up time are the most under-reported items. Both are central to judging attrition bias.
  • Report outcomes “over time,” not just a final total. Item 15 asks for incidence or person-time, not a single aggregate count.
  • Do not collapse exposed/unexposed into one row. Items 13 and 14 need to be reported separately by exposure group.

Where it falls short

Without it — two cohort-specific audits, 2011 and 2016

Reviewing 60 post-STROBE cohort studies, Poorolajal et al. found 23.6% of applicable sub-items unreported overall; efforts to address bias and the flow diagram were each missing in 85% of studies, sensitivity analyses in 73.3%. Separately, Rao et al. reviewed 37 pre-dialysis CKD cohort studies before and after STROBE and found reporting of losses to follow-up rose from 0% to only 36%, while the underlying study-design quality (Newcastle-Ottawa Scale) showed no improvement at all — STROBE improved what authors wrote, not necessarily how rigorously the studies were designed.

Poorolajal J, Cheraghi Z, Doosti Irani A, Rezaeian S. “Quality of Cohort Studies Reporting Post the STROBE Statement.” Epidemiology and Health, 2011;33:e2011005; and Rao A, Brück K, Methven S, et al. “Quality of Reporting and Study Design of CKD Cohort Studies Assessing Mortality in the Elderly Before and After STROBE.” PLoS ONE, 2016;11(5):e0155078. doi.org/10.1371/journal.pone.0155078.

Common questions

The cohort version asks for eligibility, selection sources and follow-up methods; case-control asks for case ascertainment and control selection instead.

Over time — incidence across the follow-up period, not a single cumulative total.

Yes — both prospective and retrospective/historical cohorts, since the defining feature is the exposure-to-outcome cohort structure, not when follow-up occurred.

References and sources

  1. von Elm E, Altman DG, Egger M, et al., for the STROBE Initiative. The STROBE Statement: guidelines for reporting observational studies — cohort studies. Annals of Internal Medicine 2007;147(8):573–577. read 8 October 2026. doi.org/10.7326/0003-4819-147-8-200710160-00010
  2. EQUATOR Network. STROBE checklist, cohort studies (v4). read 8 October 2026. equator-network.org

Each source carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 8). The STROBE Cohort Checklist: Where Its Wording Differs from Case-Control and Cross-Sectional. Pubrica. https://pubrica.com/insights/checklist/strobe-cohort-study-checklist/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Pubrica AcademyWritten and maintained by the subject matter experts of Pubrica who do this work. Articles are revised when the standard underneath them moves, and each one carries the date it was last checked.

How Pubrica helps

Pubrica’s biostatistics team builds the cohort-specific items — follow-up time, loss to follow-up, exposure-group reporting — around your actual dataset before the manuscript is drafted.

Find something else

Search the rest of the Academy.

Open with no account. Type what you are working on, or open the full library to filter by category, sub-topic or resource type.

Tell us the follow-up design before we start the checklist.

A scoping read costs nothing and takes two business days. You get a written view of what the work needs and who would hold it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.